skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 201,722  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: language: Japanese remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study
Material Type:
Article
Add to My Research

Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study

BMC cancer, 2021-09, Vol.21 (1), p.1-1045, Article 1045 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08766-9 ;PMID: 34556087

Full text available

2
Heterogeneity of cancer‐associated fibroblasts: Opportunities for precision medicine
Material Type:
Article
Add to My Research

Heterogeneity of cancer‐associated fibroblasts: Opportunities for precision medicine

Cancer science, 2020-08, Vol.111 (8), p.2708-2717 [Peer Reviewed Journal]

2020 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;ISSN: 1349-7006 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.14537 ;PMID: 32573845

Full text available

3
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Material Type:
Article
Add to My Research

Combination of CTLA-4 and PD-1 blockers for treatment of cancer

Journal of experimental & clinical cancer research, 2019-06, Vol.38 (1), p.255-255, Article 255 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1756-9966 ;ISSN: 0392-9078 ;EISSN: 1756-9966 ;DOI: 10.1186/s13046-019-1259-z ;PMID: 31196207

Full text available

4
Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature
Material Type:
Article
Add to My Research

Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature

PloS one, 2012-12, Vol.7 (12), p.e50946-e50946 [Peer Reviewed Journal]

COPYRIGHT 2012 Public Library of Science ;COPYRIGHT 2012 Public Library of Science ;2012 Zhang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2012 Zhang et al 2012 Zhang et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0050946 ;PMID: 23284651

Full text available

5
Cancer statistics, 2022
Material Type:
Article
Add to My Research

Cancer statistics, 2022

CA: a cancer journal for clinicians, 2022-01, Vol.72 (1), p.7-33 [Peer Reviewed Journal]

2022 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society ;2022 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Jan/Feb 2022 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21708 ;PMID: 35020204

Full text available

6
PD-1 blockade inhibits osteoclast formation and murine bone cancer pain
Material Type:
Article
Add to My Research

PD-1 blockade inhibits osteoclast formation and murine bone cancer pain

The Journal of clinical investigation, 2020-07, Vol.130 (7), p.3603-3620 [Peer Reviewed Journal]

COPYRIGHT 2020 American Society for Clinical Investigation ;COPYRIGHT 2020 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Jul 2020 ;2020 American Society for Clinical Investigation 2020 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/jci133334 ;PMID: 32484460

Full text available

7
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Material Type:
Article
Add to My Research

Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

Cancer communications (London, England), 2019-04, Vol.39 (1), p.1-12 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0368-6 ;PMID: 31030667

Full text available

8
Cancer statistics, 2023
Material Type:
Article
Add to My Research

Cancer statistics, 2023

CA: a cancer journal for clinicians, 2023-01, Vol.73 (1), p.17-48 [Peer Reviewed Journal]

2023 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Jan/Feb 2023 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21763 ;PMID: 36633525

Full text available

9
Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
Material Type:
Article
Add to My Research

Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy

Journal of hematology and oncology, 2019-05, Vol.12 (1), p.54-54, Article 54 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-019-0738-1 ;PMID: 31151482

Full text available

10
Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT
Material Type:
Article
Add to My Research

Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT

Molecular cancer, 2019-03, Vol.18 (1), p.40-40, Article 40 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-019-0959-5 ;PMID: 30866952

Full text available

11
TIM-3, a promising target for cancer immunotherapy
Material Type:
Article
Add to My Research

TIM-3, a promising target for cancer immunotherapy

OncoTargets and therapy, 2018-01, Vol.11, p.7005-7009 [Peer Reviewed Journal]

COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 He et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1178-6930 ;EISSN: 1178-6930 ;DOI: 10.2147/ott.s170385 ;PMID: 30410357

Full text available

12
Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer
Material Type:
Article
Add to My Research

Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer

Molecular cancer, 2019-03, Vol.18 (1), p.68-68, Article 68 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-019-0972-8 ;PMID: 30927911

Full text available

13
Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway
Material Type:
Article
Add to My Research

Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway

Molecular cancer, 2019-02, Vol.18 (1), p.20-20, Article 20 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-018-0935-5 ;PMID: 30717751

Full text available

14
Classification of circulating tumor cells by epithelial-mesenchymal transition markers
Material Type:
Article
Add to My Research

Classification of circulating tumor cells by epithelial-mesenchymal transition markers

PloS one, 2015-04, Vol.10 (4), p.e0123976-e0123976 [Peer Reviewed Journal]

COPYRIGHT 2015 Public Library of Science ;COPYRIGHT 2015 Public Library of Science ;2015 Wu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Wu et al 2015 Wu et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0123976 ;PMID: 25909322

Full text available

15
Plasma free amino acid profiling of five types of cancer patients and its application for early detection
Material Type:
Article
Add to My Research

Plasma free amino acid profiling of five types of cancer patients and its application for early detection

PloS one, 2011-09, Vol.6 (9), p.e24143-e24143 [Peer Reviewed Journal]

COPYRIGHT 2011 Public Library of Science ;COPYRIGHT 2011 Public Library of Science ;2011 Miyagi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Miyagi et al. 2011 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0024143 ;PMID: 21915291

Full text available

16
The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors
Material Type:
Article
Add to My Research

The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors

Journal for immunotherapy of cancer, 2019-10, Vol.7 (1), p.278-278, Article 278 [Peer Reviewed Journal]

The Author(s). ;COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/ ), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 2051-1426 ;EISSN: 2051-1426 ;DOI: 10.1186/s40425-019-0768-9 ;PMID: 31655605

Full text available

17
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Material Type:
Article
Add to My Research

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

CA: a cancer journal for clinicians, 2018-11, Vol.68 (6), p.394-424 [Peer Reviewed Journal]

2018 American Cancer Society ;2018 American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Nov/Dec 2018 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21492 ;PMID: 30207593

Full text available

18
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
Material Type:
Article
Add to My Research

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

Journal of experimental & clinical cancer research, 2019-02, Vol.38 (1), p.87-13, Article 87 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1756-9966 ;ISSN: 0392-9078 ;EISSN: 1756-9966 ;DOI: 10.1186/s13046-019-1085-3 ;PMID: 30777100

Full text available

19
Nanotechnology in cancer diagnosis: progress, challenges and opportunities
Material Type:
Article
Add to My Research

Nanotechnology in cancer diagnosis: progress, challenges and opportunities

Journal of hematology and oncology, 2019-12, Vol.12 (1), p.137-137, Article 137 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-019-0833-3 ;PMID: 31847897

Full text available

20
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Material Type:
Article
Add to My Research

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2019-12, Vol.30 (12), p.1856-1883 [Peer Reviewed Journal]

ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdz400 ;PMID: 31549998

Full text available

Results 1 - 20 of 201,722  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (188,342)

Refine My Results

New Records 

  1. New From Last Month  (6)
  2. New From Last 3 Month  (60)
  3. More options open sub menu

Subject 

  1. Science & Technology  (178,335)
  2. Life Sciences & Biomedicine  (160,756)
  3. Humans  (136,818)
  4. Oncology  (102,532)
  5. Cancer Research  (94,628)
  6. Female  (67,008)
  7. Cancer  (57,633)
  8. Male  (53,900)
  9. Tumors  (52,750)
  10. Animals  (49,317)
  11. Biological And Medical Sciences  (42,391)
  12. Middle Aged  (41,973)
  13. Medical Sciences  (38,105)
  14. General Medicine  (37,590)
  15. Aged  (35,729)
  16. Adult  (31,133)
  17. Mice  (29,877)
  18. Cell Line, Tumor  (28,591)
  19. Molecular Biology  (25,396)
  20. Cell Biology  (24,948)
  21. More options open sub menu

Language 

  1. English  (197,205)
  2. Portuguese  (132)
  3. Norwegian  (117)
  4. German  (61)
  5. Russian  (53)
  6. French  (48)
  7. Chinese  (32)
  8. Polish  (6)
  9. Dutch  (5)
  10. Korean  (4)
  11. Spanish  (4)
  12. Turkish  (3)
  13. Latin  (1)
  14. Italian  (1)
  15. Croatian  (1)
  16. Welsh  (1)
  17. Afrikaans  (1)
  18. Danish  (1)
  19. More options open sub menu

Searching Remote Databases, Please Wait